- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mucopolysaccharidosis I (MPS I)
Total 1831 results
-
Xian Children's HospitalCompletedthe Efficacy and Performance of the Pediatric I-gel MaskChina
-
Dana-Farber Cancer InstituteMedWaves, IncNot yet recruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
University Hospital, Clermont-FerrandOrigio A/SUnknownOocytes Vitrified at Prophase-I Stage | Oocytes Matured in VitroFrance
-
Isofol Medical ABCompletedPhase I Study in Healthy Volunteers to Evaluate ECG EffectSweden
-
Statens Serum InstitutEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Ministry...CompletedAids, Cdc Group IGuinea-Bissau
-
State University of New York at BuffaloCompletedDental Malocclusion | Crowding, Tooth | Angle Class II | Angle Class IUnited States
-
Allergy TherapeuticsWithdrawnType I HypersensitivityCanada
-
Allergy TherapeuticsCompleted
-
University Hospital, GhentTerminatedASA Class I/II Patients Scheduled for Surgery Under General AnesthesiaBelgium
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Herlev HospitalUnknownInteraction Between the GH/IGF-I System and the Immune-systemDenmark
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
St. Jude Children's Research HospitalRecruitingMucopolysaccharidosis I | Severe Combined Immunodeficiency | Neuroblastoma | Neoplasm | Malignancy, HematologicUnited States
-
ShireCovance; PRA Health Sciences; PharmaNetCompletedMucopolysaccharidosis II | Hunter Syndrome | MPS IIBrazil, Poland, Taiwan
-
Allergy TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States, Canada, United Kingdom, Austria
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Lexent Bio, Inc.TerminatedDetection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"Neoplasms, Non-hematologic - Stage I-IIIUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBipolar I DisorderUnited States, Argentina
-
Allergy TherapeuticsCompletedType I HypersensitivityGermany
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedBipolar I DisorderUnited States
-
University of California, San FranciscoDuke UniversityRecruitingWolman Disease | MPS IVA | Pompe Disease Infantile-Onset | Gaucher Disease, Type 2 | MPS VI | MPS I | Gaucher Disease, Type 3 | MPS II | Mps VIIUnited States
-
AbbVieRecruitingDepression | Bipolar I DisorderUnited States, Puerto Rico, Russian Federation
-
Ain Shams UniversityCompletedEasy Insertion, Complications Ans Suitability of i Gel and Air Q LMAEgypt
-
University of British ColumbiaCompleted
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompleted
-
Vastra Gotaland RegionAstraZenecaRecruitingNSCLC, Stage IFinland, Norway, Sweden
-
SunovionCompletedBipolar I DisorderUnited States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
-
Eli Lilly and CompanyCompletedBipolar I DisorderJapan
-
University of Texas Southwestern Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical Center and other collaboratorsCompletedBipolar I Disorder, Unspecified, With Psychotic Features | Bipolar I Disorder, Unspecified, Without Psychotic FeaturesUnited States
-
University Hospital Pierre Zobda-QuitmanTerminatedHTLV-I-Associated Myelopathy
-
University of ConnecticutMedical Research Council, South AfricaRecruitingHIV I InfectionUnited States
-
Centre hospitalier de l'Université de Montréal...Active, not recruiting
-
Hospital Civil de GuadalajaraCompleted
-
State University of New York - Downstate Medical...National Institute of Mental Health (NIMH); Yale UniversityEnrolling by invitationHIV I InfectionUnited States
-
IVI BilbaoCompletedEndometriosis I-II
-
Bionor Immuno ASCelgene CorporationCompleted
-
Imperial College LondonCompletedHTLV-I-associated MyelopathyUnited Kingdom
-
InnoRa GmbHTerminatedLesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/IIGermany
-
Bionor Immuno ASCompletedHIV I InfectionGermany, United States, Spain, United Kingdom, Italy
-
University of British ColumbiaAstraZeneca; Ozmosis Research Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Lung Cancer Stage I | Lung Adenocarcinoma, Stage I | Lung Squamous Cell Carcinoma Stage ICanada
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Centre Hospitalier EsquirolCompletedDepression Psychotic Feature | Severe Bipolar I Disorder (Diagnosis) | Bipolar I Disorder, Most Recent Episode Mixed, in Remission | Mood-Incongruent DelusionFrance
-
Catalyst BiosciencesTerminatedPrevious Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyUnited States